18F-Sodium fluoride PET-CT visualizes disease activity in chronic nonbacterial osteitis in adults

Anne T Leerling; Frits Smit; Zita Spӓth; Ana Navas Cañete; Lioe-Fee de Geus-Oei; Alina van de Burgt; Olaf M Dekkers; Wouter van der Bruggen; Natasha M Appelman-Dijkstra; Dennis Vriens; Elizabeth M Winter

doi:10.1093/jbmrpl/ziad007

¹⁸F-Sodium fluoride PET-CT visualizes disease activity in chronic nonbacterial osteitis in adults

JBMR Plus. 2024 Jan 4;8(2):ziad007. doi: 10.1093/jbmrpl/ziad007. eCollection 2024 Feb.

Authors

Anne T Leerling^{1

2

3}, Frits Smit^{2

4

5}, Zita Spӓth^{1

2}, Ana Navas Cañete^{2

4}, Lioe-Fee de Geus-Oei^{2

4

6}, Alina van de Burgt⁵, Olaf M Dekkers^{1

3}, Wouter van der Bruggen⁷, Natasha M Appelman-Dijkstra^{1

2}, Dennis Vriens^{2

4}, Elizabeth M Winter^{1

2}

Affiliations

¹ Department of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
² Center for Bone Quality, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
³ Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
⁴ Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
⁵ Department of Nuclear Medicine, Alrijne Hospital, Leiderdorp, 2353 GA, The Netherlands.
⁶ Department of Radiation Science and Technology, Delft University of Technology, Delft, 2628 CD, The Netherlands.
⁷ Department of Nuclear Medicine, Slingeland Hospital, Doetinchem, 7009 BL, The Netherlands.

Abstract

Chronic nonbacterial osteitis (CNO) is a rare disease spectrum, which lacks biomarkers for disease activity. Sodium fluoride-18 positron emission tomography/computed tomography ([¹⁸F]NaF-PET/CT) is a sensitive imaging tool for bone diseases and yields quantitative data on bone turnover. We evaluated the capacities of [¹⁸F]NaF-PET/CT to provide structural and functional assessment in adult CNO. A coss-sectional study was performed including 43 adult patients with CNO and 16 controls (patients referred for suspected, but not diagnosed with CNO) who underwent [¹⁸F]NaF-PET/CT at our expert clinic. Structural features were compared between patients and controls, and maximal standardized uptake values (SUV_max [g/mL]) were calculated for bone lesions, soft tissue/joint lesions, and reference bone. SUV_max was correlated with clinical disease activity in patients. Structural assessment revealed manubrial and costal sclerosis/hyperostosis and calcification of the costoclavicular ligament as typical features associated with CNO. SUV_max of CNO lesions was higher compared with in-patient reference bone (mean paired difference: 11.4; 95% CI: 9.4-13.5; p < .001) and controls (mean difference: 12.4; 95%CI: 9.1-15.8; p < .001). The highest SUV_max values were found in soft tissue and joint areas such as the costoclavicular ligament and manubriosternal joint, and these correlated with erythrocyte sedimentation rate in patients (correlation coefficient: 0.546; p < .002). Our data suggest that [¹⁸F]NaF-PET/CT is a promising imaging tool for adult CNO, allowing for detailed structural evaluation of its typical bone, soft-tissue, and joint features. At the same time, [¹⁸F]NaF-PET/CT yields quantitative bone remodeling data that represent the pathologically increased bone turnover and the process of new bone formation. Further studies should investigate the application of quantified [18F]NaF uptake as a novel biomarker for disease activity in CNO, and its utility to steer clinical decision making.

Keywords: CNO; PET/CT; SAPHO; biomarker; bone inflammation; bone turnover; osteitis; osteomyelitis.